At what time is a reduction of medical under- or overtreatment sensible? Treatment of acute depression as an example

被引:11
作者
Gandjour, A [1 ]
Lauterbach, KW [1 ]
机构
[1] Univ Cologne, Inst Gesundheitsokon & Klin Epidemiol, D-50935 Cologne, Germany
关键词
D O I
10.1055/s-2003-814805
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: 1) To portray the mathematical relationship between the size of an underuse or overuse problem caused by non-compliance of health professionals and the cost-effectiveness of a quality improvement program; 2) to demonstrate the applicability of the models to a real-world problem (underuse and overuse in the treatment of major depression) and to stress the importance of the costs of a quality improvement program using this example. Methods: Mathematical formulation of the relationship between the costs of a quality improvement program and the degree of underuse and overuse. Results: The example of reducing underuse in the treatment of major depression shows that an intervention with a favorable cost-effectiveness ratio may be economically unattractive if a quality improvement program incurs high costs secondary to a small quality deficit. The application example also shows that reducing treatment overuse is inefficient if overuse is small and hence the costs of a quality improvement program are higher than the costs of overuse. Conclusions: The explicit consideration of the size of an underuse or overuse problem in the cost-effectiveness ratio of a quality improvement program may contribute to a more efficient use of health care resources.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 18 条
[1]  
BERINGS D, 1994, EUR J CLIN PHARMACOL, V46, P501
[2]  
BOGNAR Z, 2001, ZUKUNFT DTSCH GESUND, P141
[3]  
Depression Guideline Panel, 1993, AHCPR PUBL, V2
[4]   When is it worth introducing a quality improvement program? A mathematical model [J].
Gandjour, A ;
Lauterbach, KW .
MEDICAL DECISION MAKING, 2003, 23 (06) :518-525
[5]  
Gandjour A, 2002, MED KLIN, V97, P499, DOI 10.1007/s00063-002-1188-y
[6]   A method for assessing the cost-effectiveness and the break-even point of clinical practice guidelines [J].
Gandjour, A ;
Lauterbach, KW .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2001, 17 (04) :503-516
[7]  
*KASS BUND, 1999, EINH BEW EBM
[8]   Cost-effectiveness of treatments for major depression in primary care practice [J].
Lave, JR ;
Frank, RG ;
Schulberg, HC ;
Kamlet, MS .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (07) :645-651
[9]   Depression in the community: The first pan-European study DEPRES (Depression Research in European Society) [J].
Lepine, JP ;
Gastpar, M ;
Mendlewicz, J ;
Tylee, A .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 (01) :19-29
[10]  
LOHSE MJ, 2000, ARZNEIVERORDNUNGS RE, P557